1 / 3

BRIC IVD Market: Future Insights and Demand across Major Geographies

The BRIC IVD Market and other emerging countries is expected to reach USD 15.71 Billion by 2022 from USD 10.60 Billion in 2017, at a CAGR of 8.2%.

poonam26
Télécharger la présentation

BRIC IVD Market: Future Insights and Demand across Major Geographies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. BRIC IVD Market: Future Insights and Demand across Major Geographies The rising incidence of chronic diseases, growth in the number of private diagnostic centers, and rising consolidation of laboratories are the key factors driving the market growth. However, inadequate reimbursement and the slow growth of the economy are the factors restraining the growth of this market. Download FREE Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198 How Market is Growing? The BRIC IVD Market and other emerging countries is expected to reach USD 15.71 Billion by 2022 from USD 10.60 Billion in 2017, at a CAGR of 8.2%. Based on product & service, the market is segmented into reagents & kits, instruments, services, and data management software. The reagents & kits segment accounted for the largest share of the market in 2016. On the basis of application, the market is segmented into diabetes, infectious diseases, oncology/cancer, cardiology, HIV/AIDS, autoimmune diseases, nephrology, drug testing/pharmacogenomics, and other applications. In 2016, China accounted for the largest share in the market, followed by Brazil. Rising government initiatives and improving healthcare infrastructure, and increasing geriatric population are driving the market growth in China. Brazil accounted for second-largest share in the BRIC IVD Market and other emerging countries

  2. Top Key Players The BRIC IVD Market and other emerging countries is highly competitive in nature, with the top five companies accounting for the major market share in 2016. Some key players in this market are Roche Diagnostics (Switzerland), Abbott Laboratories Inc. (U.S.), Siemens Healthineers (Germany), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Sysmex Corporation (Japan), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux (France), Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), QIAGEN N.V. (Germany), Ortho-Clinical Diagnostics, Inc. (U.S.), and Diasorin S.P.A. (Italy). These leading players have primarily focused on product launches, acquisitions, agreements, collaboration, partnerships, and expansions for growth in the market. Request for Sample @https://www.marketsandmarkets.com/requestsampleNew.asp?id=198 Target Audience •IVD product manufacturers •Group purchase organizations (GPOs) •Original equipment manufacturers (OEM) •Pathologists and pathology laboratories •Distributors of IVD products •Hospitals and clinics

  3. •Healthcare institutions

More Related